The Clinical Application of Affected-embryo-based SNP Haplotype Analysis for Patients with De Novo Pathogenic Mutations in PGT-M Cycles

Overview

Journal Arch Gynecol Obstet

Specialty Gynecology & Obstetrics

Date 2024 Oct 29

PMID 39470770

Authors

Jie Wang

Jun Xing

Linjun Chen

Zhenyu Diao

Linlin He

Shanshan Wang

Fei Lin

Ningyuan Zhang

Affiliations

Soon will be listed here.

Abstract

Purpose: In preimplantation genetic testing for monogenic/single gene disorders (PGT-M) cycles, direct detection of the pathogenic mutation combined with indirect haplotype analysis are recommended to achieve accurate diagnosis. However, it poses a challenge to conduct haplotype analysis for patients carried de novo pathogenetic mutations or without no identified haplotype in families. Herein, the strategy of affected-embryo-based haplotype analysis was implemented in clinical practice to provide a convenient, economical and effective way for such patients.

Materials And Methods: Eight cases with de novo mutations were recruited. Six cases found the embryo-proband from biopsied blastocysts, and two case (case5 and 6) found them from developmental arrested embryos. A total of thirty-seven biopsied blastocysts from eight PGT-M cycles were performed direct detection and affected-embryo-based single nucleotide polymorphism (SNP) haplotype analyses.

Results: Till now, five cases (case 1, 2, 3, 7, 8) had delivered healthy babies and one case (case6) achieved successful ongoing pregnancy. We reported for the first time to find proband from developmental arrested embryos to complete haplotype analyses when no carriers were found in biopsied ones in clinical practice.

Conclusion: Our study further proves and expands the application of the double-checking strategy based on affected-embryo proband and allows patients with de novo mutations or lack positive family members to benefit from the strategy.

References

McCarthy M, Smedley D, Hide W . New methods for finding disease-susceptibility genes: impact and potential. Genome Biol. 2003; 4(10):119. PMC: 328443. DOI: 10.1186/gb-2003-4-10-119. View

Dozmorov M . Disease classification: from phenotypic similarity to integrative genomics and beyond. Brief Bioinform. 2018; 20(5):1769-1780. DOI: 10.1093/bib/bby049. View

Wang Y, Hu L, Zhou T, Qi L, Xing L, Lee J . Gene therapy strategies for rare monogenic disorders with nuclear or mitochondrial gene mutations. Biomaterials. 2021; 277:121108. DOI: 10.1016/j.biomaterials.2021.121108. View

De Rycke M, Berckmoes V . Preimplantation Genetic Testing for Monogenic Disorders. Genes (Basel). 2020; 11(8). PMC: 7463885. DOI: 10.3390/genes11080871. View

Huang L, Ma F, Chapman A, Lu S, Xie X . Single-Cell Whole-Genome Amplification and Sequencing: Methodology and Applications. Annu Rev Genomics Hum Genet. 2015; 16:79-102. DOI: 10.1146/annurev-genom-090413-025352. View

Thornhill A, McGrath J, Eady R, Braude P, Handyside A . A comparison of different lysis buffers to assess allele dropout from single cells for preimplantation genetic diagnosis. Prenat Diagn. 2001; 21(6):490-7. DOI: 10.1002/pd.109. View

Geng D, Yang X, Wang R, Deng S, Li L, Hu X . A novel stopgain mutation c.G992A (p.W331X) in TACR3 gene was identified in nonobstructive azoospermia by targeted next-generation sequencing. J Clin Lab Anal. 2018; 33(3):e22700. PMC: 6818563. DOI: 10.1002/jcla.22700. View

Wang Y, Zhai F, Guan S, Yan Z, Zhu X, Kuo Y . A comprehensive PGT-M strategy for ADPKD patients with de novo PKD1 mutations using affected embryo or gametes as proband. J Assist Reprod Genet. 2021; 38(9):2425-2434. PMC: 8490604. DOI: 10.1007/s10815-021-02188-z. View

Chen L, Diao Z, Xu Z, Zhou J, Yan G, Sun H . The clinical application of single-sperm-based SNP haplotyping for PGD of osteogenesis imperfecta. Syst Biol Reprod Med. 2018; 65(1):75-80. DOI: 10.1080/19396368.2018.1472315. View

10.

Altarescu G, Eldar-Geva T, Varshower I, Brooks B, Haran E, Margalioth E . Real-time reverse linkage using polar body analysis for preimplantation genetic diagnosis in female carriers of de novo mutations. Hum Reprod. 2009; 24(12):3225-9. DOI: 10.1093/humrep/dep293. View

11.

Huang C, Zheng B, Chen L, Diao Z, Zhou J . The clinical application of single-sperm-based single-nucleotide polymorphism haplotyping for PGT of patients with genetic diseases. Reprod Biomed Online. 2021; 44(1):63-71. DOI: 10.1016/j.rbmo.2021.09.008. View

12.

Findikli N, Kahraman S, Kumtepe Y, Donmez E, Benkhalifa M, Biricik A . Assessment of DNA fragmentation and aneuploidy on poor quality human embryos. Reprod Biomed Online. 2004; 8(2):196-206. DOI: 10.1016/s1472-6483(10)60516-0. View

13.

Gardner D, Vella P, Lane M, Wagley L, Schlenker T, Schoolcraft W . Culture and transfer of human blastocysts increases implantation rates and reduces the need for multiple embryo transfers. Fertil Steril. 1998; 69(1):84-8. DOI: 10.1016/s0015-0282(97)00438-x. View

14.

Alfarawati S, Fragouli E, Colls P, Stevens J, Gutierrez-Mateo C, Schoolcraft W . The relationship between blastocyst morphology, chromosomal abnormality, and embryo gender. Fertil Steril. 2010; 95(2):520-4. DOI: 10.1016/j.fertnstert.2010.04.003. View

15.

Li N, Wang L, Wang H, Ma M, Wang X, Li Y . The Performance of Whole Genome Amplification Methods and Next-Generation Sequencing for Pre-Implantation Genetic Diagnosis of Chromosomal Abnormalities. J Genet Genomics. 2015; 42(4):151-9. DOI: 10.1016/j.jgg.2015.03.001. View

16.

Wang J, Diao Z, Zhu L, Zhu J, Lin F, Jiang W . Trophectoderm Mitochondrial DNA Content Associated with Embryo Quality and Day-5 Euploid Blastocyst Transfer Outcomes. DNA Cell Biol. 2021; 40(5):643-651. DOI: 10.1089/dna.2020.6271. View

17.

Kadour-Peero E, Feferkorn I, Bellemare V, Arab S, Buckett W . A comparison of frozen-thawed embryo transfer protocols in 2920 single-blastocyst transfers. Arch Gynecol Obstet. 2022; 306(3):887-892. DOI: 10.1007/s00404-022-06588-z. View

18.

Dimitriadou E, Melotte C, Debrock S, Esteki M, Dierickx K, Voet T . Principles guiding embryo selection following genome-wide haplotyping of preimplantation embryos. Hum Reprod. 2017; 32(3):687-697. DOI: 10.1093/humrep/dex011. View

19.

Wallace M, Andersen L, Saulino A, Gregory P, Glover T, Collins F . A de novo Alu insertion results in neurofibromatosis type 1. Nature. 1991; 353(6347):864-6. DOI: 10.1038/353864a0. View

20.

Bata B, Hodge D, Mohney B . Neurofibromatosis Type 1: A Population-Based Study. J Pediatr Ophthalmol Strabismus. 2019; 56(4):243-247. DOI: 10.3928/01913913-20190321-02. View